Joshua Niznik, Pharm.D., Ph.D.
Assistant Professor, Pharmaceutical Outcomes and Policy

(919) 843-3013
jdniznik@email.unc.edu
ADDRESS
5017C Old Clinic Building, , CB# 7550, Chapel Hill, NC, 27599
DOWNLOAD CV
BS: University of Pittsburgh, 2013
PharmD: University of Pittsburgh, 2015
PhD: University of Pittsburgh, 2019
Pharmacist: UPMC Magee-Women’s Hospital, 2015-2019
Postdoctoral Scholar: University of Pittsburgh, 2017-2019
Research Health Science Specialist: VA Pittsburgh Health System, 2016-present
reverse chronological order, up to 10 high impact articles
- Niznik JD, Hunnicutt J, Zhao X, Mor MK, Sileanu F, Aspinall SL, Springer SP, Ersek MJ, Gellad WF, Schleiden LJ, Hanlon JT, Thorpe JM, Thorpe CT. Deintensification of Diabetes Medications among Veterans at the End-of-Life in VA Nursing Homes. J Am Geriatr Soc. (in press).
- Niznik JD, Zhao XZ, He W, Aspinall SL, Hanlon JT, Hanson LC, Nace DA, Thorpe JT, Thorpe, CT. Risk for Health Events After Deprescribing AChEIs in Nursing Home Residents with Severe Dementia. J Am Geriatr Soc. (in press).
- Niznik JD, Zhao XZ, He W, Aspinall SL, Hanlon JT, Nace DA, Thorpe JT, Thorpe, CT. Impact of Deprescribing AChEIs on Aggressive Behaviors and Antipsychotic Prescribing. Alzheimer’s and Dementia (in press).
- Springer SP, Mor MK, Sileanu F, Zhao X, Aspinall SL, Ersek M, Niznik JD, Hanlon JT, Hunnicutt J, Gellad WF, Thorpe JM, Thorpe CT. Incidence and Predictors of Aspirin Discontinuation in Older Veteran Nursing Home Residents at End-of-Life. J Am Geriatr Soc (in press).
- Niznik JD, Zhao XZ, He W, Aspinall SL, Hanlon JT, Nace DA, Thorpe JT, Thorpe, CT. Factors associated with de-prescribing AChEIs in older nursing home residents with severe dementia. J Am Geriatr Soc. 2019 Jun 4.
- Thorpe CT, Gellad WF, Mor MK, Cashy JP, Pleis JR, Van Houtven CH, Schleiden LJ, Hanlon JT, Niznik JD, Carico RL, Good CB, Thorpe JM. Effect of dual use of Veterans Affairs (VA) and Medicare Part D drug benefits on antihypertensive refill adherence in a national cohort of Veterans with dementia. Health Services Research. 2018 Dec;53 Suppl 3:5375-5401.
- Niznik JD, Zhang S, Mor M, Zhao X, Ersek M, Aspinall S, Thorpe J, Gellad W, Hanlon J, Schleiden L, Springer S, Thorpe C. Adaptation and Initial Validation of the Minimum Data Set (MDS) Mortality Risk Index to MDS version 3.0. J Am Geriatr Soc. 2018 Dec;66(12):2353-2359.
- Schleiden LJ, Thorpe CT, Cashy JP, Gellad WF, Good CB, Hanlon JT, Mor MK, Niznik JD, Pleis JR, Van Houtven CH, Thorpe JM. Characteristics of dual drug benefit use among veterans with dementia enrolled in the Veterans Health Administration and Medicare Part D. Res Social Adm Pharm. 2018 Sep 8. pii: S1551-7411(18)30387-5.
- Niznik JD, Zhao X, Jiang T, Hanlon J, Aspinall S, Thorpe J, Thorpe C. Anticholinergic Prescribing in Medicare Part D Beneficiaries Residing in Nursing Homes: Results from a retrospective cross-sectional analysis of Medicare data. Drugs & Aging 2017 Dec;34(12):925-939.
- Aspinall S, Hanlon JT, Niznik JD, Springer S, Thorpe CT. Deprescribing in Older Nursing Home Patients: Focus on Innovative Composite Measures for Dosage Deintensification. Innovation in Aging 2017. Dec 20;1(2):igx031.
View complete list of publications on PubMed. https://www.ncbi.nlm.nih.gov/myncbi/1FES97Vq5z2Qm/bibliography/public/
Recently Completed
Project Number: A21-0467 (PI: J. Niznik)
Title: De-prescribing Bisphosphonates in Nursing Home Residents with Dementia
Source: US Deprescribing Research Network (1R24AG064025)
Total Direct Costs (Sub-award only): $37,691
Dates: 08/01/2020-07/31/2021
Role: Principal Investigator
Project Number: N/A (Co-PIs: C. Thorpe and Aspinall)
Title: De-prescribing of anti-dementia medications
Source: The Patrick and Catherine Weldon Donaghue Foundation
Total Direct Costs (Sub-award only): $125,672
Dates: 9/1/2018-10/31/2019
Role: Co-Investigator
Project Number: N/A (Co-PIs: J. Niznik and C. Thorpe)
Title: De-prescribing of anti-dementia medications
Source: The Pittsburgh Claude D. Pepper Older Americans Independence Center
Total Direct Costs: $24,897
Dates: 2/02/2018-8/31/2018
Role: Co-Principal Investigator
US Deprescribing Research Network Junior Investigator Intensive
The American Geriatrics Society Scientist-in Training Research Award, 2018
American Geriatrics Society Best Paper Award, Health Services & Policy Research, 2018
UPMC Aging Institute Best Postdoctoral Clinical Research Award, 2018
University of Pittsburgh Randy and Renee Juhl Pharmacy Graduate Scholar Award, 2018
University of Pittsburgh School of Medicine Health Services/Clinical Epidemiology Post-Doctoral Fellow Research Award, 2018
Top Reviewer for Research in Social and Administrative Pharmacy, 2017